IQVIA
4820 Emperor Boulevard
Durham
North Carolina
27703
United States
Tel: 866-267-4479
Website: https://www.iqvia.com/
780 articles about IQVIA
-
IQVIA CFO Ron Bruehlman to Speak at Baird Global Healthcare Conference on September 13, 2023
9/5/2023
IQVIA Holdings Inc., announced that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Baird 2023 Global Healthcare Conference in New York City on Wednesday, September 13, 2023 at 10:50 a.m. ET.
-
IQVIA Reports Second-Quarter 2023 Results
8/1/2023
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended June 30, 2023.
-
The Federal Trade Commission’s increased scrutiny of mergers has now hit IQVIA, whose proposed acquisition of Propel Media has been challenged by the watchdog agency.
-
IQVIA to Announce Second-Quarter 2023 Results on August 1, 2023
7/6/2023
IQVIA Holdings Inc. will announce its second-quarter 2023 financial results before the market opens on Tuesday, August 1, 2023.
-
IQVIA selected ‘Leader’ in Everest Group Life Sciences Sales and Marketing Operations PEAK Matrix® Assessment 2023
6/29/2023
IQVIA™, a global provider of data, analytics, technology solutions and services to the life sciences industry, was recognized as the highest scoring provider in the ‘Leader’ category of Everest Group’s Life Sciences Sales and Marketing Operations PEAK Assessment.
-
IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening
5/25/2023
IQVIA™ announced a groundbreaking partnership with, the organization co-founded by Bono and Bobby Shriver to fight AIDS and the injustices that enable pandemics to thrive, to support laboratory system strengthening and save lives.
-
Global Oncology R&D Activity Remains High and More Patients Have Been Treated for Cancer, says IQVIA Institute for Human Data Science
5/24/2023
Global research and development activity in oncology remained at historically high levels in 2022, up 22% from 2018, and the global number of patients treated with approved medicines increased at an average of 5% annually over the same period, according to a new report from the IQVIA Institute for Human Data Science on Global Oncology Trends 2023.
-
IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes and Senior Notes
5/18/2023
IQVIA Holdings Inc. announced that its wholly-owned subsidiary, IQVIA Inc., priced an offering of $1,250,000,000 in aggregate principal amount of senior notes, which was upsized due to strong demand, consisting of $750,000,000 in aggregate principal amount of senior secured notes due 2028 and $500,000,000 in aggregate principal amount of senior notes due 2030.
-
IQVIA Announces Offering of Senior Secured Notes and Senior Notes
5/18/2023
IQVIA Holdings Inc. (NYSE:IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $1,000,000,000 through an offering of senior secured notes due 2028 and senior notes due 2030 (collectively, the “Notes”).
-
IQVIA Celebrates Sheetal Telang, Winner of Healthcare Businesswoman's Association Rising Star Award
5/11/2023
IQVIA announced that Sheetal Telang, vice president of Therapeutic Strategy, has been honored with the 2023 Rising Star award by the Healthcare Businesswoman's Association.
-
Use of Medicines in the U.S. Continued to Grow in 2022 while Patient Out-of-Pocket Costs Remain Low, Says IQVIA Institute
5/2/2023
The U.S. market for medicines grew by 5% in 2022, reaching a total value of $429Bn on a net price basis.
-
IQVIA Reports First-Quarter 2023 Results; Reaffirms Full-Year 2023 Guidance
4/27/2023
IQVIA Reports First-Quarter 2023 Results; Reaffirms Full-Year 2023 Guidance.
-
IQVIA Named a Leader in Everest Group Life Sciences Customer Experience Platforms PEAK Matrix® Assessment 2023
4/20/2023
IQVIA™ announces the company has been recognized as a Leader in Customer Experience Platforms by Everest Group for its Orchestrated Customer Engagement platform.
-
IQVIA to Announce First-Quarter 2023 Results on April 27, 2023
4/6/2023
IQVIA Holdings Inc. will announce its first-quarter 2023 financial results before the market opens on Thursday, April 27, 2023.
-
Florence Healthcare Now Equipping IQVIA Research Sites With Site Enablement Technology
3/14/2023
Florence Healthcare and IQVIA have entered a multiyear collaboration to ensure research sites participating in IQVIA studies have access to site enablement technology.
-
IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023
3/1/2023
IQVIA Holdings Inc., announced that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays Global Healthcare Conference in Miami, FL on Wednesday, March 15, 2023 at 9:30 a.m. ET.
-
IFPW Launches Environmental, Social, and Corporate Governance (ESG) Framework To Serve as a Resource for the Pharmaceutical Industry
2/24/2023
The International Federation of Pharmaceutical Wholesalers, in partnership with member companies including global healthcare company AmerisourceBergen and IQVIA, a leading provider of advanced analytics and technology solutions, launched an ESG framework and toolkit to serve as a resource for the industry.
-
IQVIA Publishes its 2022 Environmental, Social and Governance Report
2/23/2023
IQVIA (NYSE:IQV) has published its 2022 Environmental, Social and Governance (ESG) Report.
-
IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance
2/10/2023
IQVIA Holdings Inc., a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, reported financial results for the quarter ended December 31, 2022.
-
IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China
1/31/2023
IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the pharmaceutical and broader life sciences industry, today announces the first life sciences industry collaboration with Alibaba Cloud in China.